文献速递脑血管病

可逆性脑血管收缩综合征表现、病因及结局的地区差异

Regional Differences in Presentation, Cause, and Outcome of Reversible Cerebral Vasoconstriction Syndrome.
PubMed 文献 · Stroke · 2025-06-26

该研究基于RCVS国际协作网络的多中心观察队列,汇总1127例确诊RCVS患者(欧洲528例、亚洲599例),比较脑 lesions、3个月不良结局及病因的地区差异。欧洲患者脑 lesions、继发性RCVS及不良结局的 odds 均显著高于亚洲患者,但作者指出可能反映医疗结构差异导致的选择偏倚。

要点

  • 欧洲RCVS患者脑 lesions 发生率29.2%,亚洲6.3%,OR 4.09(95%CI 2.66-6.30)。
  • 欧洲患者继发性RCVS占50.4%,亚洲10.9%,OR 7.09(95%CI 5.14-9.76)。
  • 欧洲患者3个月不良结局5.5%,亚洲1.7%,OR 3.01(95%CI 1.35-6.68)。

核心结论

  • RCVS的表现存在地区差异,欧洲患者的脑 lesions 率、继发性比例及不良结局均高于亚洲患者。

研究设计与样本

  • 基于RCVS国际协作网络的多中心观察队列,探索性汇总个体患者数据,纳入2个法国、32个意大利、1个韩国和1个台湾中心的1127例确诊RCVS患者(欧洲528例,亚洲599例)。

主要发现

  • 欧洲患者脑 lesions 发生率29.2%,亚洲患者6.3%,OR 4.09(95%CI 2.66-6.30)。
  • 欧洲患者继发性RCVS占50.4%,亚洲患者10.9%,OR 7.09(95%CI 5.14-9.76)。
  • 欧洲患者3个月不良结局(mRS≥1)占5.5%,亚洲患者1.7%,OR 3.01(95%CI 1.35-6.68)。
  • 亚裔患者65.8%从门诊招募,欧洲患者99.8%从急诊招募。

关键数值与推荐

  • 主要终点为RCVS相关脑 lesions,包括缺血性卒中、皮质蛛网膜下腔出血、脑出血、后部可逆性脑病综合征和硬膜下血肿。
  • 次要终点包括3个月不良结局(mRS≥1)和病因(特发性 vs 继发性)。

临床怎么用

  • 临床遇到RCVS患者时,应结合地区来源评估脑 lesions 和继发性病因的风险,欧洲患者需更警惕继发性病因及不良结局。

局限性

  • 探索性分析结果可能反映不同医疗结构导致的选择偏倚。
  • 遗传、环境和社会因素的贡献尚需进一步研究确定。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: National studies on reversible cerebral vasoconstriction syndrome (RCVS) point to differences between Asian and European patients. We investigated geographic variations in neurological complications, outcomes, and causes. METHODS: We conducted an exploratory analysis of pooled individual patient data from the Reversible Cerebral Vasoconstriction Syndrome International Collaborative network, a multicenter observational cohort study including patients with definite RCVS from 2 French, 32 Italian, 1 South Korean, and 1 Taiwanese centers. Data on demographics, precipitants, symptoms, imaging, treatment, and outcomes were collected. The primary end point was RCVS-associated brain lesions, including ischemic stroke, cortical subarachnoid hemorrhage, intracerebral hemorrhage, posterior reversible encephalopathy syndrome, and subdural hematoma. Secondary end points included unfavorable 3-month outcomes (modified Rankin Scale score ≥1) and causes (idiopathic versus secondary). Odds ratios and 95% CIs were calculated using multivariable logistic regression, adjusting for potential confounders. RESULTS: From 2009 to 2021, we included 1127 patients (528 European and 599 Asian). Recruitment occurred either through emergency settings or outpatient clinics, with most Asian patients recruited from outpatient clinics (65.8%) and most European patients from emergency settings (99.8%). Brain lesions were more frequent in European patients (29.2% versus 6.3%; odds ratio, 4.09 [95% CI, 2.66-6.30]). In a sensitivity analysis restricted to hospitalized patients (n=651), the association persisted. Unfavorable 3-month outcomes (5.5% versus 1.7%; odds ratio, 3.01 [95% CI, 1.35-6.68]) and secondary RCVS (50.4% versus 10.9%; odds ratio, 7.09 [95% CI, 5.14-9.76]) were also associated with European residency. CONCLUSIONS: RCVS presentations vary across regions, with higher lesion rates, more secondary forms, and worse outcomes in European patients. While these exploratory results may reflect selection bias from differing health care structures, further research is needed to determine the contribution of genetic, environmental, and societal factors.

来源:Stroke,查看原文。版权归原作者所有。

引用

  1. Lange KS, Wang SJ, Pezzini A, et al. Regional Differences in Presentation, Cause, and Outcome of Reversible Cerebral Vasoconstriction Syndrome. Stroke. 2025. PMID: 40567225. doi:10.1161/STROKEAHA.125.051733

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。